Bremer Bank National Association’s Edwards Lifesciences EW Stock Holding History

Bremer Bank National Association’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,117	Closed	-$296K	–	201
2022 Q2	$296K	Hold	3,117	–	–	0.06%	173
2022 Q1	$367K	Sell	3,117 -457	-13%	-$51.3K	0.06%	162
2021 Q4	$463K	Hold	3,574	–	–	0.08%	151
2021 Q3	$405K	Sell	3,574 -552	-13%	-$63K	0.08%	140
2021 Q2	$427K	Sell	4,126 -444	-10%	-$41.9K	0.09%	138
2021 Q1	$382K	Hold	4,570	–	–	0.09%	150
2020 Q4	$417K	Sell	4,570 -513	-10%	-$42.6K	0.1%	138
2020 Q3	$406K	Sell	5,083 -434	-8%	-$33.9K	0.11%	133
2020 Q2	$381K	Sell	5,517 -192	-3%	-$13.6K	0.11%	131
2020 Q1	$359K	Sell	5,709 -351	-6%	-$25.3K	0.1%	141
2019 Q4	$472K	Sell	6,060 -399	-6%	-$31.2K	0.1%	149
2019 Q3	$473K	Sell	6,459 -1,119	-15%	-$78.6K	0.1%	149
2019 Q2	$467K	Hold	7,578	–	–	0.1%	154
2019 Q1	$445K	Buy	+7,578	New	+$432K	0.09%	170

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bremer Bank National Association's EW Position: Q3 2022 in Review

Bremer Bank National Association sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 3,117 shares — an estimated $296K sold.

Bremer Bank National Association first reported a position in EW in Q1 2019 and held it in 14 quarters. The position peaked at $473K in Q3 2019. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Bremer Bank National Association reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
Bremer Bank National Association sold 3,117 Edwards Lifesciences shares in Q3 2022, an estimated $296K.
Bremer Bank National Association first reported a position in Edwards Lifesciences in Q1 2019 and held it in 14 quarters.
Bremer Bank National Association's Edwards Lifesciences position peaked at $473K in Q3 2019.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Bremer Bank National Association's 13F filing for Q3 2022, filed 12 Oct 2022.